Evidence map›Paper›PMID 24525709›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.

Eddie N Billingslea, Valerie M Tatard-Leitman, Jaynie Anguiano, Catherine R Jutzeler, Jimmy Suh, John A Saunders, Susumu Morita, Robert E Featherstone, Pavel I Ortinski, Michael J Gandal and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Synaptic dysfunction and adaptation after NMDA receptor ablation in the mouse medial prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Eddie N BillingsleaDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Valerie M Tatard-LeitmanDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Jaynie AnguianoDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Catherine R JutzelerDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Jimmy SuhDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
John A SaundersDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Susumu MoritaDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Robert E FeatherstoneDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Pavel I OrtinskiDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Michael J GandalDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Robert LinDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Yuling LiangDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Raquel E GurDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Gregory C CarlsonDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Chang-Gyu HahnDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Steven J SiegelDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · US

Funding

NMDA Receptor Hypofunction in the Amygdala of Schizophrenia PatientsP50MH096891 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2012 to 2016
$10.6M
SCHIZOPHRENIA: A NEUROPSYCHIATRIC PERSPECTIVET32MH019112 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 1990 to 2024
$6.2M
An Implantable Semiannual Antipsychotic Delivery SystemR01MH074672 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SIEGEL, STEVEN J · 2007 to 2014
$2.3M
Long-term neurobehavioral effects of ketamine exposure in adolescent miceR01DA023210 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI SIEGEL, STEVEN J · 2008 to 2012
$1.9M
Control of Cocaine Seeking by D1-dependent Modulation of NMDA SignalingK01DA031747 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ORTINSKI, PAVEL IVANOVICH · 2012 to 2016
$696k
NIDA NIH HHS 5R01DA023210-04NIDA NIH HHS K01 DA031747NIDA NIH HHS R01 DA023210NIMH NIH HHS 1P50MH096891-01NIMH NIH HHS 32MH019112NIMH NIH HHS 5R01MH074672 -04NIMH NIH HHS P50 MH096891NIMH NIH HHS R01 MH074672NIMH NIH HHS T32 MH019112
6 · The paper itself

Abstract

NMDA-receptor (NMDAR) hypofunction is strongly implicated in the pathophysiology of schizophrenia. Several convergent lines of evidence suggest that net excitation propagated by impaired NMDAR signaling on GABAergic interneurons may be of particular interest in mediating several aspects of schizophrenia. However, it is unclear which behavioral domains are governed by a net increase of excitation and whether modulating downstream GABAergic signaling can reverse neural and thus behavioral deficits. The current study determines the selective contributions of NMDAR dysfunction on PV-containing interneurons to electrophysiological, cognitive, and negative-symptom-related behavioral phenotypes of schizophrenia using mice with a PVcre-NR1flox-driven ablation of NR1 on PV-containing interneurons. In addition, we assessed the efficacy of one agent that directly modulates GABAergic signaling (baclofen) and one agent that indirectly modifies NMDAR-mediated signaling through antagonism of mGluR5 receptors (2-methyl-6-(phenylethynyl) pyridine (MPEP)). The data indicate that loss of NMDAR function on PV interneurons impairs self-care and sociability while increasing N1 latency and baseline gamma power, and reducing induction and maintenance of long-term potentiation. Baclofen normalized baseline gamma power without corresponding effects on behavior. MPEP further increased N1 latency and reduced social behavior in PVcre/NR1+/+ mice. These two indices were negatively correlated before and following MPEP such that as N1 latency increases, sociability decreases. This finding suggests a predictive role for N1 latency with respect to social function. Although previous data suggest that MPEP may be beneficial for core features of autism spectrum disorders, current data suggest that such effects require intact function of NMDAR on PV interneurons.

Indexed as

Self CareAnimalsBaclofenBrainDisease Models, AnimalEvoked PotentialsExcitatory Amino Acid AntagonistsExploratory BehaviorGABA AgonistsInterpersonal RelationsMaze LearningMiceMice, Inbred C57BLMice, TransgenicNerve Tissue ProteinsNeurons6-methyl-2-(phenylethynyl)pyridineBaclofenExcitatory Amino Acid AntagonistsGABA AgonistsGprin1 protein, mouseNerve Tissue ProteinsParvalbuminsPyridinesReceptors, N-Methyl-D-Aspartate

Identifiers

PMID24525709
PMCPMC4023157
OpenAlexW1991748689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.